Our previous study showed that miR-129-2, which targets sex determining region Y-box 4 (SOX4) and cyclin-dependent kinase 6 (CDK6), was frequently methylated in CLL at diagnosis [11, 35, 36]. The gene discussed is CDK6; the disease is B-cell chronic lymphocytic leukemia.